University of Lyon System-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2024

  1. Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer–a plain language summary

    Future Oncology, Vol. 20, Núm. 22, pp. 1531-1544

2023

  1. Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer

    European Journal of Cancer, Vol. 189

2016

  1. Routine Clinical Practice for Patients with Recurrent Ovarian Carcinoma: Results from the TROCADERO Study

    International Journal of Gynecological Cancer, Vol. 26, Núm. 2, pp. 240-247